|
Q1 FY2027
As of Jun 30, 2026
|
Q4 FY2026
As of Mar 31, 2026
|
Q3 FY2026
As of Dec 31, 2025
|
Q2 FY2026
As of Sep 30, 2025
|
Q1 FY2026
As of Jun 30, 2025
|
Q4 FY2025
As of Mar 31, 2025
|
Q3 FY2025
As of Dec 31, 2024
|
Q2 FY2025
As of Sep 30, 2024
|
Q1 FY2025
As of Jun 30, 2024
|
Q4 FY2024
As of Mar 31, 2024
|
Q3 FY2024
As of Dec 31, 2023
|
Q2 FY2024
As of Sep 30, 2023
|
Q1 FY2024
As of Jun 30, 2023
|
Q4 FY2023
As of Mar 31, 2023
|
Q3 FY2023
As of Dec 31, 2022
|
Q2 FY2023
As of Sep 30, 2022
|
Q1 FY2023
As of Jun 30, 2022
|
Q4 FY2022
As of Mar 31, 2022
|
Q3 FY2022
As of Dec 31, 2021
|
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Amounts due from related parties | |||||||||||||||||||
| Inventories | |||||||||||||||||||
| Deferred financing cost, net | |||||||||||||||||||
| Prepayment | |||||||||||||||||||
| Deposits, and other receivables | |||||||||||||||||||
| Cash and cash equivalents | |||||||||||||||||||
| Deferred financing cost | |||||||||||||||||||
| Deferred financing expenses | |||||||||||||||||||
| Accounts receivable | |||||||||||||||||||
| Deposits | |||||||||||||||||||
| Deposits, prepayments and other receivables | |||||||||||||||||||
| Amount due from a related party | |||||||||||||||||||
| Total current assets | |||||||||||||||||||
| Property and equipment, net | |||||||||||||||||||
| Right-of-use assets | |||||||||||||||||||
| Intangible assets, net | |||||||||||||||||||
| Total non-current assets | |||||||||||||||||||
| TOTAL ASSETS | |||||||||||||||||||
| Accounts payable | |||||||||||||||||||
| Accrued liabilities and other payables | |||||||||||||||||||
| Promissory notes | |||||||||||||||||||
| Promissory note, related party | |||||||||||||||||||
| Accrued consulting and service fee | |||||||||||||||||||
| Advances received from customer | |||||||||||||||||||
| Advance received from customer | |||||||||||||||||||
| Lease liabilities | |||||||||||||||||||
| Amounts due to related parties | |||||||||||||||||||
| Total current liabilities | |||||||||||||||||||
| TOTAL LIABILITIES | |||||||||||||||||||
| Preferred stock, value | |||||||||||||||||||
| Preferred Stock | |||||||||||||||||||
| Series A Preferred Stock | |||||||||||||||||||
| Series B Preferred Stock | |||||||||||||||||||
| Series C Preferred Stock | |||||||||||||||||||
| Common stock, par value $0.0001, 36,000,000,000 shares authorized, 10,881,149 and 10,881,149 shares issued and outstanding as of June 30, 2026 and March 31, 2026, respectively | |||||||||||||||||||
| Common stock to be issued | |||||||||||||||||||
| Common stock to be cancelled | |||||||||||||||||||
| Deferred compensation | |||||||||||||||||||
| Additional paid-in capital | |||||||||||||||||||
| Accumulated other comprehensive income | |||||||||||||||||||
| Accumulated deficit | |||||||||||||||||||
| Stockholders’ deficit | |||||||||||||||||||
| TOTAL LIABILITIES AND STOCKHOLDERS’ DEFICIT | |||||||||||||||||||
Loading...
